Sero-Prevalence of Hepatitis B and Hepatitis C in District Sialkot: Prevalence of Hepatitis B and C in Sialkot

Asma Waheed Qureshi; Farah Jabeen; Madiha Mehmood

doi:10.54393/pjhs.v5i12.990

Authors

Asma Waheed Qureshi Department of Zoology, Government College Women University, Sialkot, Pakistan
Farah Jabeen Department of Zoology, Government College Women University, Sialkot, Pakistan
Madiha Mehmood Department of Zoology, Government College Women University, Sialkot, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i12.990

Keywords:

Hepatitis B, Hepatitis C, Incidence, Sero-Prevalence

Abstract

Hepatitis B and hepatitis C are peak overwhelming infectious conditions belonging to liver inflammation. According to the World Health Organization's hepatitis report, 96% of the 1.3 million hepatitis virus-related fatalities annually, of which 720,000 happened at the cirrhosis stage, were the result of chronic infections with the hepatitis B and hepatitis C viruses. Objectives: To assess the sero-prevalence of Hepatitis B and Hepatitis C in District Sialkot. Methods: A total of 1,737 blood samples were randomly collected from participants who visited the hospital for hepatitis screening from March 2018 to August 2018. All the samples were screened via Immune-chromatographic strip test. Statistical analysis was performed on data using IBM SPSS Statistics (Version 27). Results: A total of 15.5% samples tested positive, out of which 12.43% samples were hepatitis C viruses and 2.82% were hepatitis B viruses positive respectively. Overall prevalence was higher in male (16.60%) than female 14.19%. Sero-prevalence was high between the age group of 61-80 years. Likewise, among married persons (17.16%) as compared to unmarried (8.01%). Conclusions: It was concluded that a significant association of prevalence of hepatitis with both age and marital status (p<0.001) was observed, while no significant effect was on gender.

References

Weinbaum CM, Mast EE, Ward JW. Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection. Hepatology. 2009 May; 49(S5): S35-44. doi: 10.1002/hep.22882. DOI: https://doi.org/10.1002/hep.22882

Basit A, Rahim K, Ahmad I, Shafiq M, Mushtaq S, Shaheen H et al. Prevalence of Hepatitis B and C Infection in Pakistan. Journal of Infection and Molecular Biology. 2014 May; 2(3): 35-8. doi: 10.14737/jimb.2307-5465/2.3.35.38. DOI: https://doi.org/10.14737/jimb.2307-5465/2.3.35.38

Zanetti AR, Van Damme P, Shouval D. The Global Impact of Vaccination Against Hepatitis B: A Historical Overview. Vaccine. 2008 Nov; 26(49): 6266-73. doi: 10.1016/j.vaccine.2008.09.056. DOI: https://doi.org/10.1016/j.vaccine.2008.09.056

Norder H, Couroucé AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK et al. Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Sub-Genotypes, and HBs Ag Subtypes. Intervirology. 2004 Nov; 47(6): 289-309. doi: 10.1159/000080872. DOI: https://doi.org/10.1159/000080872

Rehermann B and Nascimbeni M. Immunology of Hepatitis B Virus and Hepatitis C Virus Infection. Nature Reviews Immunology. 2005 Mar; 5(3): 215-29. doi: 10.1038/nri1573. DOI: https://doi.org/10.1038/nri1573

Seeger C and Mason WS. Molecular Biology of Hepatitis B Virus Infection. Virology. 2015 May; 479: 672-86. doi: 10.1016/j.virol.2015.02.031. DOI: https://doi.org/10.1016/j.virol.2015.02.031

World Health Organization. Global Health Sector Strategy On Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis. World Health Organization. 2016.

Ferri C, Sebastiani M, Giuggioli D, Colaci M, Fallahi P, Piluso A et al. Hepatitis C Virus Syndrome: A Constellation of Organ and Non-Organ Specific Autoimmune Disorders, B-Cell Non-Hodgkin’s Lymphoma, and Cancer. World Journal of Hepatology. 2015 Mar; 7(3): 327. doi: 10.4254/wjh.v7.i3.327. DOI: https://doi.org/10.4254/wjh.v7.i3.327

Adams MJ, Lefkowitz EJ, King AM, Harrach B, Harrison RL, Knowles NJ et al. Changes to Taxonomy and the International Code of Virus Classification and Nomenclature Ratified by the International Committee on Taxonomy of Viruses (2017). Archives of virology. 2017 Aug; 162(8): 2505-38. doi: 10.1007/s00705-017-3358-5. DOI: https://doi.org/10.1007/s00705-017-3358-5

Tang H and Grisé H. Cellular and Molecular Biology of HCV Infection and Hepatitis. Clinical Science. 2009 Jul; 117(2): 49-65. doi: 10.1042/CS20080631. DOI: https://doi.org/10.1042/CS20080631

Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of Viral Clearance and Persistence During Acute Hepatitis C Virus Infection. The Journal of Experimental Medicine. 2001 Nov; 194(10): 1395-406. doi: 10.1084/jem.194.10.1395. DOI: https://doi.org/10.1084/jem.194.10.1395

Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1988 Through 1994. New England Journal of Medicine. 1999 Aug; 341(8): 556-62. doi: 10.1056/NEJM199908193410802. DOI: https://doi.org/10.1056/NEJM199908193410802

Jamma S, Hussain G, Lau DT. Current Concepts of HBV/HCV Coinfection: Coexistence, But Not Necessarily in Harmony. Current Hepatitis Reports. 2010 Nov; 9: 260-9. doi: 10.1007/s11901-010-0060-4. DOI: https://doi.org/10.1007/s11901-010-0060-4

Sheldon J and Soriano V. Hepatitis B Virus Escape Mutants Induced by Antiviral Therapy. Journal of Antimicrobial Chemotherapy. 2008 Apr; 61(4): 766-8. doi: 10.1093/jac/dkn014. DOI: https://doi.org/10.1093/jac/dkn014

Umar M and Bilal M. Hepatitis C, A Mega Menace: A Pakistani Perspective. Journal of Pioneering Medical Sciences. 2012 Jun; 2: 68-72.

Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N et al. The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors. Journal of American and Medical Association. 2000 Jul; 284(4): 450-6. doi: 10.1001/jama.284.4.450. DOI: https://doi.org/10.1001/jama.284.4.450

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of Worldwide Prevalence of Chronic Hepatitis B Virus Infection: A Systematic Review of Data Published Between 1965 and 2013. The Lancet. 2015 Oct; 386(10003): 1546-55. doi: 10.1016/S0140-6736(15)61412-X. DOI: https://doi.org/10.1016/S0140-6736(15)61412-X

Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The Influence of Age On the Development of the Hepatitis B Carrier State. Proceedings of the Royal Society of London. Series B: Biological Sciences. 1993 Aug; 253(1337): 197-201. doi: 10.1098/rspb.1993.0102. DOI: https://doi.org/10.1098/rspb.1993.0102

Bostan N, Naeem M, Afzal MS, Shah ZH, Mustafa I, Arshad M et al. Sero-Prevalence of Hepatitis B and C Virus from Rural Areas of Northern Punjab (Sargodha District), Pakistan. Tropical Biomedicine. 2016; 33(4): 599–607.

Mahmood M, Anwar MA, Khanum A, Zaman N, Raza A. Distribution and Clinical Significance of Hepatitis B Virus Genotypes in Pakistan. BioMed Central Gastroenterology. 2016 Dec; 16: 1-9. doi: 10.1186/s12876-016-0513-5. DOI: https://doi.org/10.1186/s12876-016-0513-5

Parlati L, Hollande C, Pol S. Treatment of Hepatitis C Virus Infection. Clinics and Research in Hepatology and Gastroenterology. 2021 Jul; 45(4): 101578. doi: 10.1016/j.clinre.2020.11.008. DOI: https://doi.org/10.1016/j.clinre.2020.11.008

Khan JK, Lone DS, Hameed A, Munim R, Bhatti M, Khattak AA et al. Evaluation of the Performance of Two Rapid Immune-Chromatographic Tests for Detection of Hepatitis B Surface Antigen and Anti-HCV Antibodies Using ELISA Tested Samples. Annals of King Edward Medical University. 2010; 16(1 SI). doi: 10.21649/akemu.v16i1%20SI.166.

Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical Outcomes After Transfusion-Associated Hepatitis C. New England Journal of Medicine. 1995 Jun; 332(22): 1463-6. doi: 10.1056/NEJM199506013322202. DOI: https://doi.org/10.1056/NEJM199506013322202

Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and Hepatitis C in Pakistan: Prevalence and Risk Factors. International Journal of Infectious Diseases. 2009 Jan; 13(1): 9-19. doi: /10.1016/j.ijid.2008.06.019. DOI: https://doi.org/10.1016/j.ijid.2008.06.019

Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SF, Jafar T et al. Hepatitis B and C: Prevalence and Risk Factors Associated with Sero-Positivity among Children in Karachi, Pakistan. BioMed Central Infectious Diseases. 2006 Dec; 6: 1-0. doi: 10.1186/1471-2334-6-101. DOI: https://doi.org/10.1186/1471-2334-6-101

Kakepoto GN, Bhally HS, Khaliq G, Kayani N, Burney IA, Siddiqui T et al. Epidemiology of Blood-Borne Viruses: A Study of Healthy Blood Donors in Southern Pakistan. The Southeast Asian Journal of Tropical Medicine and Public Health. 1996 Dec; 27(4): 703-6.

Mirza IA, Mirza SH, Irfan S, Siddiqi R, Tariq WU, Janjua AN. Sero-Prevalence of Hepatitis B and C in Young Adults Seeking Recruitment in Armed Forces. Pakistan Armed Forces Medical Journal. 2006 Jun; 56(2): 192-7.

Chaudhary IA, Khan SS, Majrooh MA, Alvi AA. Sero-Prevalence of Hepatitis-B and C among the Patients Reporting in Surgical OPD at Fauji Foundation Hospital, Rawalpindi: Review of 5-Year Literature. Pakistan Journal of Medical Sciences. 2007 Jul; 23(4): 514.

Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C Virus in Pakistan: A Systematic Review of Prevalence, Genotypes and Risk Factors. World Journal of Gastroenterology. 2009 Dec; 15(45): 5647. doi: 10.3748/wjg.15.5647. DOI: https://doi.org/10.3748/wjg.15.5647

Ali A, Ahmad H, Ali I, Khan S, Zaidi G, Idrees M. Prevalence of Active Hepatitis C Virus Infection in District Mansehra Pakistan. Virology Journal. 2010 Dec; 7: 1-5. doi: 10.1186/1743-422X-7-334. DOI: https://doi.org/10.1186/1743-422X-7-334

Ilyas M and Ahmad I. Chemiluminescent Microparticle Immunoassay Based Detection and Prevalence of HCV Infection in District Peshawar Pakistan. Virology Journal. 2014 Dec; 11: 1-5. doi: 10.1186/1743-422X-11-127. DOI: https://doi.org/10.1186/1743-422X-11-127